학술논문
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study
Document Type
Article
Author
Source
In American Journal of Kidney Diseases June 2016 67(6):912-924
Subject
Language
ISSN
0272-6386